IVERIC bio Inc. (ISEE)
NASDAQ: ISEE
· Real-Time Price · USD
39.95
0.15 (0.38%)
At close: Jul 10, 2023, 10:00 PM
IVERIC bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -73.84M | -62.97M | -42.51M | -49.75M | -34.67M | -33.03M | -24.58M | -30.21M | -26.87M |
Interest Income | 3.46M | 1.45M | 200K | 482K | 133K | 61K | 42K | 65K | 77K |
Pretax Income | -72.23M | -59.06M | -42.35M | -49.26M | -34.54M | -33.03M | -24.55M | -30.14M | -26.8M |
Net Income | -70.62M | -59.06M | -42.35M | -48.29M | -34.54M | -33.03M | -24.55M | -30.14M | -26.8M |
Selling & General & Admin | 31.76M | 27.13M | 17.55M | 16.11M | 12.11M | 8M | 6.65M | 6.72M | 8.32M |
Research & Development | 42.08M | 35.84M | 24.97M | 33.65M | 22.56M | 25.1M | 17.93M | 23.49M | 18.55M |
Other Expenses | n/a | 92K | -39K | 8K | 1K | n/a | n/a | n/a | n/a |
Operating Expenses | 73.84M | 62.97M | 42.51M | 49.75M | 34.67M | 33.1M | 24.58M | 30.21M | 26.87M |
Interest Expense | n/a | 1.45M | 200K | 482K | 133K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 73.84M | 62.97M | 42.51M | 49.75M | 34.67M | 33.1M | 24.58M | 30.21M | 26.87M |
Income Tax Expense | -1.61M | -7.79M | -396K | -972K | -267K | 64K | 32K | 63K | 76K |
Shares Outstanding (Basic) | 137.09M | 121.04M | 120.28M | 119.69M | 118.75M | 115.07M | 105.22M | 93.41M | 93.31M |
Shares Outstanding (Diluted) | 137.09M | 121.04M | 120.28M | 119.69M | 118.75M | 115.07M | 105.22M | 93.41M | 93.31M |
EPS (Basic) | -0.52 | -0.47 | -0.35 | -0.4 | -0.29 | -0.29 | -0.23 | -0.32 | -0.29 |
EPS (Diluted) | -0.52 | -0.47 | -0.35 | -0.4 | -0.29 | -0.29 | -0.23 | -0.32 | -0.29 |
EBITDA | -73.77M | -65.34M | -42.51M | -49.73M | -34.65M | -33.02M | -24.55M | -30.14M | -26.78M |
EBIT | -73.84M | -57.61M | -42.15M | -48.78M | -34.4M | -33.03M | -24.58M | -30.21M | -26.87M |
Depreciation & Amortization | 70K | -2.37M | 35K | 24K | 21K | 15K | 6K | 5K | 13K |